Search for Clinical Trial Results
Chromophil Renal Cell Carcinoma - 25 Studies Found
Status | Study |
Recruiting |
Study Name: Cabozantinib-S-Malate, Crizotinib, Volitinib, or Sunitinib Malate in Treating Patients With Locally Advanced or Metastatic Kidney Cancer Condition:
Interventions: |
Active, not recruiting |
Study Name: Bevacizumab With or Without TRC105 in Treating Patients With Metastatic Kidney Cancer Condition:
|
Terminated |
Study Name: Sorafenib and Interferon Alfa in Treating Patients With Locally Advanced or Metastatic Kidney Cancer Condition:
|
Recruiting |
Study Name: CREATE: Cross-tumoral Phase 2 With Crizotinib Condition:
|
Active, not recruiting |
Study Name: Mycophenolate Mofetil and Cyclosporine in Reducing Graft-Versus-Host Disease in Patients With Hematologic Malignancies or Metastatic Kidney Cancer Undergoing Donor Stem Cell Transplant Condition:
|
Active, not recruiting |
Study Name: Total-Body Irradiation and Fludarabine Phosphate Followed by Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies or Kidney Cancer Condition:
|
Active, not recruiting |
Study Name: Fludarabine Phosphate, Low-Dose Total Body Irradiation, and Donor Stem Cell Transplant in Treating Patients With Hematologic Malignancies or Kidney Cancer Condition:
|
Recruiting |
Study Name: A Dose Escalation, Safety and Activity Study of CDX-014 in Patients With Advanced or Metastatic Renal Cell Carcinoma Condition:
|
Completed |
Study Name: Sorafenib Tosylate and Bevacizumab in Treating Patients With Advanced Kidney Cancer Condition:
|
Completed |
Study Name: Combination Chemotherapy, Radiation Therapy, and/or Surgery in Treating Patients With High-Risk Kidney Tumors Condition:
|